The team proposed a new index structure called HATree.

In a new research paper published in MedComm-Oncology, the team of Yongsheng Li/Dairong Li/Huakan Zhao provided an effective and accurate ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) tool for the simultaneous detection of aumolertinib, osimertinib, gefitinib and their major metabolites, demonstrating the great bioavailability and tissue distribution characteristics of aumolertinib.

In a ground-breaking new development, researchers have created conductive films by mixing conductive polymers with two-dimensional carbon materials. These films can be used as electrodes to monitor a wide range of body signals when pasted on the surface of human skin, including cardiac, myoelectric, and ocular signals.

 Researchers have developed the CATCH-LIFE-MELD (Chinese Acute-on-Chronic Liver Failure Consortium-Model for end-stage liver disease) score, an improved prognostic tool for acute-on-chronic liver failure (ACLF). By incorporating age, neutrophil count, and hepatic encephalopathy grade into the traditional MELD score, this model offers more accurate predictions of 28- and 90-day mortality, outperforming current methods. This advancement aids in identifying high-risk patients, optimizing treatment strategies, and guiding future therapies, promising better outcomes for those with ACLF.